Reduced Intensity Conditioning for Allogeneic Hematopoietic Cell Transplantation: Current Perspectives
Open Access
- 31 January 2007
- journal article
- review article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 13 (1 Suppl 1) , 87-97
- https://doi.org/10.1016/j.bbmt.2006.10.015
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Adoptive Immunotherapy by Allogeneic Stem Cell Transplantation for Metastatic Renal Cell Carcinoma: A CALGB Intergroup Phase II StudyTransplantation and Cellular Therapy, 2006
- Inflammatory Cytokines Predominate in Cases of Tumor Regression after Hematopoietic Stem Cell Transplantation for Solid CancerTransplantation and Cellular Therapy, 2006
- Allogeneic Hematopoietic Cell Transplantation as Immunotherapy for Solid TumorsJournal of Immunotherapy, 2005
- Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning for Advanced Chronic Lymphocytic LeukemiaJournal of Clinical Oncology, 2005
- Reduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia with multilineage dysplasia using fludarabine, busulphan, and alemtuzumab (FBC) conditioningBlood, 2004
- Nonmyeloablative TransplantationClinical Cancer Research, 2004
- BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patientsBlood, 2004
- Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantationBlood, 2003
- HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignanciesBlood, 2003
- Differential CD52 expression by distinct myeloid dendritic cell subsets: implications for alemtuzumab activity at the level of antigen presentation in allogeneic graft-host interactions in transplantationBlood, 2003